Merck & Co. Inc.’s stock rose 2% premarket Tuesday, after the company reported positive results for a new, ...
AstraZeneca and Amgen announced that a Phase 3 trial of Tezspire (tezepelumab) showed a statistically significant and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback